Suzhou’s total number of listed companies has surpassed 300 following Denglin Technology’s debut on the Hong Kong Stock Exchange on Nov. 10, marking a milestone for the city’s capital market and the latest achievement in its high-quality economic development.
Suzhou is currently home to 238 A-share listed companies, ranking fifth nationwide. Among them, 60 are on the STAR Market (3rd nationwide), 71 on the ChiNext (4th nationwide), and 22 on the Beijing Stock Exchange (2nd nationwide). With this latest listing, the total number of Suzhou companies listed domestically and overseas has surpassed 300.
Suzhou’s listed companies are highly concentrated in key fields such as next-generation information technology, high-end equipment, new materials, new energy, and biomedicine. They are characterized by expanding scale, strong sci-tech credentials, improving quality, leading industry champions, and accelerated innovation, representing a shift from quantitative growth to sci-tech leadership and quality upgrading.
As of October 31, the total market capitalization of Suzhou’s A-share listed companies has exceeded 2.67 trillion yuan, with five companies each valued at over 100 billion yuan. Among overseas-listed companies, Innovent Biologics also boasts a market cap exceeding 100 billion yuan. In the first three quarters of 2026, the 238 Suzhou A-share listed companies recorded a combined R&D spending of roughly 31.05 billion yuan, up 18.56% year on year; their total revenue reached approximately 732.032 billion yuan, up 12.29%; and their combined net profit attributable to parent companies stood at around 61.743 billion yuan, up 43.48%.
